Ipsen is a mid-sized public biopharmaceutical company operating across three therapeutic areas with a pipeline supported by nearly a century of development experience and presence in 40+ countries. The tech stack reflects a mature pharma organization—Salesforce Health Cloud + Veeva for regulatory submissions, Snowflake + Databricks for data infrastructure, and enterprise Microsoft 365 backbone—but the adopting list (LC-MS/MS, SAP S/4HANA) signals modernization of compliance and supply-chain operations, a critical focus given the pain-point frequency around GMP and regulatory adherence.
Notable leadership hires: Account Director, Corporate Account Director, Chief of Staff, Medical Lead Oncology, Clinical Science Director
Ipsen develops and commercializes medicines across oncology, rare disease, and neuroscience, reaching patients in 88 countries through a distributed operating model anchored in the U.S., France, and the U.K. The company maintains research capabilities rooted in peptide and toxin science. Hiring velocity is accelerating across 330 open roles globally—notably in healthcare (clinical and compliance functions), sales, and marketing—with leadership development around medical and clinical science roles, reflecting expansion in therapeutic expertise and market access.
Ipsen's primary stack includes Salesforce (Health Cloud, Marketing Cloud, Data Cloud), Veeva for regulatory submissions, Snowflake + Redshift + Databricks for analytics, SAP for ERP, Microsoft 365, Power Platform, and GitHub Copilot. They're adopting LC-MS/MS (analytical chemistry) and SAP S/4HANA.
Active projects include regional diagnostic treatment center establishment, educational programs for healthcare providers, rare disease network development (especially liver disease), KOL engagement, and brand/pull-through strategy execution. ESG initiatives and academic platform building are also underway.
Other companies in the same industry, closest in size